Breaking Down New FDA Rules on Decentralized Clinical Trials
Foley and Lardner attorneys discuss new Food and Drug Administration guidance on decentralized clinical trials for medication and medical devices and its impacts with health care executive Jodi Akin in this Podcast.
United States Kyle Faget Monica Chmielewski Edwards Lifesciences Firm Health Care Practice Group National Healthcare Practice Group At Foley Lardner
Source: natlawreview.com